ARDX

Ardelyx Stock Price

8.53
0.69 (8.8%)
8.53

Low
4.81

52 Week Range

High
9.23

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Ardelyx Inc ARDX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.69 8.8% 8.53 18:18:51
Open Price Low Price High Price Close Price Prev Close
7.90 7.86 9.23 8.66 7.84
Bid Price Ask Price Spread News
8.54 8.57 0.03 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
74,705 20,019,891 $ 8.69 $ 173,962,951 867,532 4.81 - 9.23
Last Trade Time Type Quantity Stock Price Currency
18:20:00 1 $ 8.57 USD

Ardelyx Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 769.82M 90.25M 73.55M $ 5.28M $ - -1.47 -7.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Ardelyx News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ARDX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week7.719.236.977.511,721,6550.8210.64%
1 Month7.069.235.916.991,851,3531.4720.82%
3 Months6.999.235.916.981,156,3081.5422.03%
6 Months5.539.234.966.76854,2123.0054.25%
1 Year7.039.234.816.67732,8701.5021.34%
3 Years5.2510.43431.605.78620,2063.2862.48%
5 Years8.1916.301.606.28502,5550.344.15%

Ardelyx Description

Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.


Your Recent History
NASDAQ
ARDX
Ardelyx
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.